Metadoze IPR Information
Metadoze IPR is an allopathic medicine The correct dosage of Metadoze IPR depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Metadoze IPR Benefits & Uses
Metadoze IPR is used to treat the following -
Main Benefits
- Diabetes (Read More - 10 Home Remedies for Diabetes)
Metadoze IPR Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Metadoze IPR Side Effects
Based on research, the following side effects have been observed when Metadoze IPR is used -
Severe
- Blurred vision
Moderate
- Palpitations (fluttering in chest)
Mild
- Nausea or vomiting
- Altered taste
- Diarrhoea
- पेट दर्द
- Loss of appetite
- Headache
- पेट की गैस
- Dyspepsia
Common
- Stomach Upset
- Difficulty urinating
Metadoze IPR Related Warnings
-
Is the use of Metadoze IPR safe for pregnant women?
Pregnant women can consume [medicine]. Though Metadoze IPR has mild side effects when taken during pregnany
Mild -
Is the use of Metadoze IPR safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Metadoze IPR. Immediately discontinue Metadoze IPR if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
Moderate -
What is the effect of Metadoze IPR on the Kidneys?
Metadoze IPR does not damage the kidneys.
Safe -
What is the effect of Metadoze IPR on the Liver?
Using Metadoze IPR does not have any harmful effects on the liver.
Safe -
What is the effect of Metadoze IPR on the Heart?
Metadoze IPR is not harmful for the heart.
Safe
Severe Interaction of Metadoze IPR with Other Drugs
Metadoze IPR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Metadoze IPR Contraindications
If you are suffering from any of the following diseases, you should not take Metadoze IPR unless your doctor advises you to do so -
- Congestive Heart Failure (CHF)
- Anemia
- Shock
- Heart Failure
- Liver Disease
- Heart Disease
- Hypoglycemia (Low Blood Sugar)
- Drug Allergy
- Kidney Disease
Frequently asked Questions about Metadoze IPR
-
Is this Metadoze IPR habit forming or addictive?
Metadoze IPR is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
Metadoze IPR will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Safe -
Is it safe?
Metadoze IPR is safe but it is important to consult a doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Metadoze IPR is unable to treat or cure mental disorders.
No
Metadoze IPR Interactions with Food and Alcohol
-
Interaction between Food and Metadoze IPR
There isn't any research available on the side effects of taking Metadoze IPR with food.
Unknown -
Interaction between Alcohol and Metadoze IPR
Taking Metadoze IPR with alcohol can have severely harmful effects on your health.
Severe
See all substitutes for Metadoze IPR
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826